We previously reported an association between the SH2D2A gene encoding TSAd and multiple sclerosis (MS). Here a total of 2128 Nordic MS patients and 2004 controls were genotyped for the SH2D2A promoter GA repeat polymorphism and rs926103 encoding a serine to asparagine substitution at amino acid position 52 in TSAd. The GA(16)-rs926103()A haplotype was associated with MS in Norwegians (OR 1.4, P=0.04). A similar trend was observed among Danes. In the independent Norwegian, Danish and Swedish sample sets the GA(16) allele showed a combined OR of 1.13, P=0.05. Thus, the present study shows that the SH2D2A gene may contribute to susceptibility to MS.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jneuroim.2008.04.037 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Transcriptional switches in melanoma T Cells: Facilitating polarizing into regulatory T cells.
Int Immunopharmacol
August 2024
Zhejiang Provincial Key Laboratory of Medical Genetics, Key Laboratory of Laboratory Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China; Department of Laboratory Medicine, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200071, China. Electronic address:
Melanoma is a malignant skin tumor with a high mortality rate. Regulatory T cells (Tregs) are immune cells with immunosuppressive roles, however, the precise mechanisms governing Treg involvement in melanoma remain enigmatic. Experimental findings unveiled different transcription factor switches between normal and tumor T cell, with heightened FOXP3 and BATF in the latter.
View Article and Find Full Text PDFBioinformatics analysis and validation of genes related to paclitaxel's anti-breast cancer effect through immunogenic cell death.
Heliyon
April 2024
School of Pharmaceutical Science & Yunnan Provincial Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, Yunnan, 650500, PR China.
Article Synopsis
- Paclitaxel (PTX) has shown potential to trigger immunogenic cell death (ICD) in breast cancer, but research on this combination is limited.
- The study utilized TCGA-BRCA and GSE20685 datasets to identify key genes related to ICD, ultimately finding 626 genes related to inflammatory response.
- Five biomarkers (CHI3L1, IL18, PAPLN, SH2D2A, and UBE2L6) were discovered to help predict treatment outcomes for breast cancer, and their effectiveness was validated using the GSE20685 dataset.
Construction and Validation of a Prognostic Model Based on Pyroptosis-related Genes in Bladder Cancer.
Comb Chem High Throughput Screen
September 2024
Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, P.R. China.
Background: Bladder cancer (BCa) is a highly prevalent disease with a poor prognosis. There is no better forecasting method for it yet. Current studies demonstrate that pyroptosis is involved in the development and progression of various cancers.
View Article and Find Full Text PDFA novel CD8 T cell-related gene signature for predicting the prognosis and immunotherapy efficacy in bladder cancer.
Inflamm Res
August 2023
Department of Urology, Urology Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, 350005, China.
Objective: To identify CD8 T cell-related molecular clusters and establish a novel gene signature for predicting the prognosis and efficacy of immunotherapy in bladder cancer (BCa).
Methods: Transcriptome and clinical data of BCa samples were obtained from the Cancer Genome Atlas (TCGA) and GEO databases. The CD8 T cell-related genes were screened through the CIBERSORT algorithm and correlation analysis.
Construction of T cell exhaustion model for predicting survival and immunotherapy effect of bladder cancer based on WGCNA.
Front Oncol
May 2023
Department of Urology Surgery, Qilu Hospital (Qingdao) of Shandong University, Qingdao, China.
Introduction: The prognosis of bladder cancer (BLCA) and response to immune checkpoint inhibitors (ICIs) are determined by multiple factors. Existed biomarkers for predicting the effect of immunotherapy cannot accurately predict the response of BLCA patients to ICIs.
Methods: To further accurately stratify patients' response to ICIs and identify potential novel predictive biomarkers, we used the known T cell exhaustion (TEX)-related specific pathways, including tumor necrosis factor (TNF), interleukin (IL)-2, interferon (IFN)-g, and T- cell cytotoxicpathways, combined with weighted correlation network analysis (WGCNA) to analyze the characteristics of TEX in BLCA in detail, constructed a TEX model.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!